Efung Capital (倚锋资本)

Efung Capital (倚锋资本) is a venture capital fund investing in China, Asia and Global, focused on Biotech and Healthcare. We hold 12 investments for them on record. 1 person is listed at the firm.

efungcapital.com
Stages
Not stated
Cheque size
Not on record

What Efung Capital (倚锋资本) invests in

Invests in innovative biopharmaceutical therapies and technologies, backing startups from preclinical to commercial stages, with portfolio including Ascletis Pharma and CanSino Biologics.

People at Efung Capital (倚锋资本)

1 named person on record.

  • Infoi•••••@efungcapital.com

Contact addresses at Efung Capital (倚锋资本) are partly hidden. Create a free account to see full addresses, a fit score against your own startup, and an outreach email written for this investor.

Efung Capital (倚锋资本) portfolio

12 investments on record. Each row says whether the round came from the fund's own portfolio page or from the press, so you can check it.

CompanySectorRoundAmountDate
LumiTheraHealthcare$14MJul 2020press
Apexigendevelops cancer therapiesHealthcareseries-c$123MMar 2020press

10 more investments on record for Efung Capital (倚锋资本).

The first two are open to everyone. A free account opens the rest — the company, the round, the amount, the date and where each number came from. No card, no demo call.

Create a free account

Investors similar to Efung Capital (倚锋资本)

Or browse the whole directory.

Write to Efung Capital (倚锋资本) with something they'll read.

Pitch2Fund scores your startup against Efung Capital (倚锋资本)'s actual thesis and portfolio, then writes the email — citing the companies they've already backed and why yours fits beside them. Free, and you keep the contacts.